The American cannabis industry is undergoing rapid transformation, fueled by the steady wave of marijuana legalization across numerous states and a growing societal acceptance of both medicinal and recreational use. With this expansion comes a soaring demand for top-tier cannabis seeds—the essential starting point for every successful grow. Amid this growth, a surprising shift has caught the eye of analysts and regulators: a European company has managed to saturate the U.S. market with cannabis seeds, doing so legally and efficiently by leveraging strategic tactics, innovative logistics, and a savvy grasp of international and federal legal loopholes.

This is the compelling account of how GreenGene International rose to become a major player in the American cannabis seed industry—all without setting foot on U.S. soil.

The Rise of Cannabis Legalization in the U.S.

To grasp the magnitude of this development, it’s essential to consider the landscape in which it’s unfolding. Over the past decade, cannabis legalization has steadily advanced across the United States. By early 2025, more than 20 states have fully legalized recreational use, while many others have approved medical marijuana or moved to decriminalize possession.

This regulatory shift has triggered a surge in demand for cannabis products—ranging from dried flower and concentrates to edibles and oils—and naturally, for the seeds that make cultivation possible. Growers at all levels, from home hobbyists to large-scale operators, are in pursuit of high-performance genetics that deliver bigger yields, stronger effects, and distinct cannabinoid profiles.

Though numerous American companies have entered the scene to meet this demand, a foreign contender has surprisingly taken the lead: a European seed supplier rapidly gaining ground in the U.S. market.

Who Is GreenGene International?

GreenGene International, headquartered in Amsterdam—the long-standing epicenter of global cannabis culture—is a Dutch cannabis seed company with more than 20 years of expertise in breeding, hybridization, and genetic refinement. Over the decades, the company has earned a stellar reputation across Europe for producing some of the most reliable and high-performing cannabis seeds available.

Their expansive portfolio features a diverse selection of feminized seeds, autoflowering varieties, and rare hybrids—many of which are the result of meticulous cross-breeding and multi-generational testing. With over 150 distinct strains in its catalog, GreenGene caters to both recreational growers seeking high-THC plants and medical cultivators in need of CBD-rich genetics.

Yet, what truly sets GreenGene apart isn’t just its exceptional product lineup—it’s the company’s ability to penetrate and thrive in the American market, all while navigating the complex maze of U.S. federal laws with remarkable precision.

Exploiting Legal Loopholes

GreenGene’s strategic brilliance lies in its deep understanding of legal technicalities—particularly how cannabis seeds are categorized under U.S. law. In 2022, the Drug Enforcement Administration (DEA) clarified that cannabis seeds containing less than 0.3% THC qualify as hemp under the 2018 Farm Bill. This federal legislation legalized hemp and all its derivatives, as long as they remain below the specified THC threshold.

This classification opened a legal pathway: cannabis seeds—regardless of their strain or eventual THC content once cultivated—could be lawfully shipped across state lines, provided they remain ungerminated and contain negligible THC. Seizing this opportunity, GreenGene swiftly expanded its seed exports to the U.S., leveraging the “hemp” designation to navigate federal restrictions.

To stay within the bounds of U.S. customs and postal regulations, GreenGene cleverly labels its products as “souvenirs,” “botanical specimens,” or “collector’s items.” This savvy marketing approach has helped the company avoid regulatory red flags, all while reaching growers in states where cannabis cultivation is permitted.

The Power of E-Commerce and Discreet Distribution

GreenGene’s expansion into the U.S. market was further powered by the rise of global e-commerce. Through their multilingual website, American customers can easily explore the entire seed collection, access comprehensive strain descriptions, and place orders seamlessly with just a few clicks. Discreet shipping methods—such as vacuum-sealed packaging and plain, unmarked labeling—help ensure that deliveries pass through customs and postal inspections without attracting attention.

Additionally, GreenGene has forged partnerships with U.S.-based resellers and gray-market distributors who manage order fulfillment and customer service within the country. These alliances allow GreenGene to maintain a strong foothold across American online communities, seed banks, and even brick-and-mortar shops—often without buyers realizing they are purchasing from an international supplier.

Why U.S. Growers Are Choosing GreenGene

American cannabis cultivators—whether casual home growers or licensed professionals—have a wide array of seed sources to choose from. Yet, GreenGene has cultivated a loyal following in the U.S. for several compelling reasons:

• Exceptional Genetics

  
  

  GreenGene’s seeds are the product of meticulous, multi-generational breeding that prioritizes plant stability, vigor, and consistency. Their feminized seeds boast an impressive 99% female rate, minimizing crop loss and boosting overall yield efficiency.

• Unique and Innovative Strains

  
  

  Pioneering new strain combinations is a hallmark of GreenGene’s work. They continually introduce cultivars with distinctive terpene profiles, accelerated flowering periods, and heightened THC or CBD content—giving U.S. growers access to cutting-edge genetics often unavailable from domestic suppliers.

• Affordability and Accessibility

  
  

  Despite the international logistics, GreenGene offers highly competitive pricing. In many cases, their seeds are more affordable than those from boutique American brands, making them especially appealing to cost-conscious growers seeking value without compromising quality.

• Proven Track Record

  
  

  With decades of experience and a well-established presence in the European market, GreenGene has earned the trust of cultivators around the world. Positive reviews, detailed grow logs, and user-generated video content have helped solidify their reputation among U.S. growers seeking reliability and authenticity.

The Impact on American Seed Companies

Not everyone is thrilled by GreenGene’s growing influence. Domestic seed producers, many of whom have operated in legal gray zones for years, are now facing stiff competition from a company with more experience, better genetics, and a wider reach.

Some American breeders accuse GreenGene of undercutting the market and bypassing the rigorous licensing and testing requirements that local companies must meet. Others warn that foreign domination of the seed market could threaten the development of unique American strains and reduce innovation at home.

Still, many growers argue that competition is healthy—and that GreenGene’s presence is pushing domestic companies to improve their offerings.

Regulatory Blind Spots

Despite the company’s widespread reach, U.S. regulators have been slow to respond to the influx of foreign cannabis seeds. That’s partly because seed regulation remains a murky area of the law. While plants and finished products are tightly controlled, seeds fall into a gray zone—especially when they contain negligible THC.

This ambiguity has created challenges for customs officers, agricultural inspectors, and state-level cannabis agencies, many of whom lack clear guidance on how to manage seed imports. Some states, like California and Oregon, have begun tightening seed licensing laws and encouraging local sourcing, but enforcement remains inconsistent.

At the federal level, the lack of cohesive cannabis legislation has left many questions unanswered. Until cannabis is legalized—or at least more clearly regulated—at the federal level, companies like GreenGene will continue to find ways to operate in the gaps.

The Globalization of Cannabis Genetics

GreenGene’s success is not just a story of clever strategy—it’s also a sign of a broader trend: the globalization of cannabis genetics.

For decades, cannabis cultivation was a highly localized activity. Growers relied on seeds passed down from mentors, bred at home, or smuggled from other regions. But with legalization spreading and international trade becoming more feasible, cannabis is quickly becoming a global crop.

European companies have a head start, having operated in more tolerant environments like the Netherlands and Spain for years. Now, they’re exporting that expertise to emerging markets in North America, Latin America, and even parts of Africa and Asia.

This globalization brings both opportunities and risks. On one hand, it expands access to high-quality seeds and fosters cross-border collaboration. On the other hand, it raises concerns about genetic homogenization, intellectual property theft, and the displacement of local breeders.

Cannabis Seed Industry at a Crossroads

The American cannabis seed market is at a critical juncture. As demand continues to soar, pressure is mounting on regulators to bring clarity and order to a system that is currently fragmented and largely self-policed.

Should the U.S. embrace international competition and open its market to global players like GreenGene? Or should it prioritize domestic breeders, standardize seed licensing, and develop robust quality control systems?

Either way, the actions taken over the next few years will shape the future of cannabis cultivation in America—determining who controls the genetics, who profits from the trade, and how the industry evolves.

Conclusion

GreenGene International’s quiet domination of the American cannabis seed market is a fascinating case study in innovation, legality, and globalization. By identifying and exploiting loopholes, investing in superior genetics, and mastering the logistics of international shipping, they’ve managed to “flood” the U.S. with cannabis seeds—legally and profitably.

Their story reflects a larger shift in the cannabis world, where national borders are becoming less important than product quality, brand reputation, and regulatory agility. As cannabis continues to grow from a subculture to a multibillion-dollar global industry, expect to see more international players shaping its future.

For American growers, this presents an exciting opportunity: access to the best cannabis genetics the world has to offer. But it also presents a challenge—to remain competitive, domestic companies will need to innovate, collaborate, and perhaps most importantly, adapt to a market that is no longer just local, but truly global.

HOW TO TELL GOOD CANNABIS SEEDS FROM BAD? READ ON…

GOOD CANNABIS SEED GUIDE – HOW CAN YOU TELL?

4/20 on Easter Sunday: A Divine Sign to Resurrect the Cannabis Movement?

This Sunday marks a rare celestial alignment—4/20, the unofficial cannabis holiday, falls on Easter Sunday. The last time these two celebrations coincided was in 2014, and before that in 2003. After this year, we’ll have to wait until 2087 for this particular convergence to happen again, according to U.S. Census data. While some might chuckle at the cosmic joke of a day celebrating resurrection overlapping with one celebrating getting high, I see something more profound: a symbolic reminder that the cannabis legalization movement itself may need a resurrection.

Despite nationwide polls showing 57% of Americans support legalizing cannabis for both medical and recreational purposes, we’re witnessing something unexpected—a legislative pushback against the green wave that has swept across America for the past decade. In state after state, politicians are targeting everything from THC potency limits to tax rates, and some are even attempting to roll back voter-approved programs entirely.

Have we grown complacent? Has the cannabis community mistaken partial victory for total triumph? As we light up this Sunday (if that’s your thing), perhaps we should reflect on the work that remains and recommit ourselves to the cause of cannabis freedom—a cause that’s as much about personal autonomy as it is about access to a plant.

It’s easy to forget that just over a decade ago, no states had legalized recreational cannabis. Today, according to the latest data, 24 states and Washington D.C. allow recreational sales, while 39 states have sanctioned medical marijuana. This rapid expansion created what Penn State’s Daniel Mallinson called “an air of inevitability” around legalization.

But that air is growing thinner.

In Idaho, where every neighboring state has legalized cannabis in some form, Republican state Rep. Bruce Skaug has led efforts to impose a mandatory $300 fine for possession and, more alarmingly, to take away voters’ right to legalize cannabis through ballot initiatives. The latter measure will appear on Idaho ballots in 2025, potentially removing the most successful pathway to legalization in numerous states.

“Looking around at other states that have legalized marijuana, it’s not improved their states as a place to raise a family, to do business,” Skaug told Stateline. “It just hasn’t come through with the promises that we heard years ago for those states.”

This sentiment isn’t isolated to deep-red Idaho. Across the country, lawmakers are targeting cannabis through various means:

• In Montana, legislators have introduced bills to cap THC content at 15% (down from the current 35%) and just passed a measure reducing edible dosage limits from 10mg to 5mg per serving

• Maryland, Michigan, New Jersey, and Ohio have all considered or implemented significant tax increases on cannabis

• In South Dakota and Nebraska, legislators have attempted to restrict voter-approved medical marijuana programs

“This year in particular, we’re playing defense a lot more than we have in the past,” warned Morgan Fox, political director at NORML. The pendulum that swung toward liberalization for a decade may now be swinging back.

As we face this political backlash, it’s worth noting how cannabis consumption itself is evolving. According to a recent Centers for Disease Control and Prevention (CDC) report analyzing 2022 data, while smoking remains the most common method (79.4% of users), eating (41.6%), vaping (30.3%), and dabbing (14.6%) cannabis are growing in popularity.

Compared to 2016 data, “the prevalences of eating and vaping marijuana were each higher in 2022,” according to the CDC report, “as was the prevalence of reporting multiple routes of use.” About half of all adult cannabis users (46.7%) reported multiple methods of consumption.

This diversification of consumption methods reflects cannabis’s movement into the mainstream. No longer just the domain of joint-rolling enthusiasts, cannabis appeals to people who prefer the precision dosing of edibles or the discretion of vape pens. The plant’s versatility has helped it reach new demographics—but it has also attracted new critics concerned about high-potency products.

Montana state Sen. Greg Hertz, a Republican who sponsored legislation to cap THC levels, put it bluntly: “People were voting for Woodstock weed, not this new high-THC marijuana.”

Despite anti-cannabis rhetoric often focusing on protecting children, the data tells a different story about youth consumption in the legalization era. According to CDC reports, as of 2023, about 17% of high-school students reported using marijuana within the past month—down significantly from 23% in 2013, when legal recreational markets were just beginning.

The decline has been particularly pronounced among male students, with rates falling from 25% in 2013 to 15% in 2023. Another report from the Substance Abuse and Mental Health Services Administration (SAMHSA) found that consumption among minors aged 12 to 20 had fallen slightly in the past year, suggesting that youth use has decreased significantly over the past decade—precisely when cannabis legalization was expanding most rapidly.

These findings directly contradict prohibitionist claims that legalization would lead to increased youth consumption. If anything, regulated markets with strict ID verification have made it harder for young people to access cannabis compared to the prohibition era when dealers never checked ID.

As we observe both Easter and 4/20 this Sunday, it’s worth reflecting on how cannabis has historically represented something more than just a recreational substance. During the counterculture movement of the 1960s and the resistance to the “Just Say No” era of the 1980s, cannabis symbolized rebellion against oppressive authority and the right to cognitive liberty.

Today, as we face new threats to cannabis freedom—from potency caps to confiscatory tax rates—perhaps it’s time to reclaim that symbolic power. Cannabis isn’t just a consumer product; it’s a declaration that adults should have sovereignty over their own consciousness.

Idaho state Rep. Ilana Rubel, a Democrat, highlighted the disconnect between public opinion and legislative action: “I think this is one of those issues where there is just a huge, huge gap between what the people of Idaho want and what they’re going to get from their legislature.” She noted that a 2022 poll found nearly 70% of Idahoans supported legalizing medical marijuana, yet the state remains firmly prohibitionist.

This democratic deficit—where politicians ignore their constituents’ wishes on cannabis—should concern anyone who values representative government, regardless of their personal views on the plant.

So how do we resurrect the cannabis movement in the face of this backlash? Here are a few suggestions:

1. Stay engaged politically: Don’t assume legalization is inevitable. Contact your representatives, register to vote, and support cannabis-friendly candidates.
2. Support equitable policies: Push for licensing frameworks that provide opportunities for those harmed by prohibition, not just deep-pocketed corporations.
3. Challenge misinformation: When you hear outdated “Reefer Madness” claims, counter them with evidence about falling youth use rates and the safety profile of cannabis compared to legal substances like alcohol.
4. Consume responsibly: If you use cannabis, do so in ways that don’t reinforce negative stereotypes. The CDC report notes that public health messaging about potential risks of different consumption methods is important—we should acknowledge this while maintaining that adults deserve the right to make informed choices.
5. Remember the medical patients: As we fight for recreational access, never forget that many people rely on cannabis for serious medical conditions. Their needs must remain central to the movement.

The calendar alignment of Easter and 4/20 this year feels symbolically significant. Just as Easter represents renewal and resurrection in the Christian tradition, perhaps this 4/20 can mark a renewal of purpose for the cannabis movement.

The fight for cannabis freedom is far from over. Ten years ago, we might have thought legalization was just around the corner nationwide. Now we know better. This plant—which helps millions medically, harms no one when used responsibly, and represents a profound statement about personal liberty—deserves our continued advocacy.

So this Sunday, whether you’re hunting eggs, lighting up, or both, take a moment to reflect on the progress we’ve made and the work that remains. The cannabis movement doesn’t need a miracle to succeed—it just needs us to stay vigilant, passionate, and engaged.

The resurrection of our commitment begins now. The next chapter of cannabis freedom is ours to write.

HAPPY EASTER, PEEPS! CLICK BELOW…

THE GREAT EASTER NUG HUNT, HAPPY EASTER CANNABIS FANS!

In recent years, the cannabis industry has experienced explosive growth, with innovative products reshaping how consumers experience cannabis. Among the most exciting developments is the emergence of THC-infused beverages—particularly cannabis seltzers—that offer a novel, convenient, and socially acceptable alternative to traditional alcohol consumption. Now, a coalition of THC-infused beverage companies is taking this trend a step further by launching a large-scale, groundbreaking study involving 2,000 participants to explore how cannabis drinks can serve as a healthier and more enjoyable substitute for alcohol.

This ambitious research initiative, backed by some of the most prominent cannabis beverage brands, aims to collect real-world data on consumer experiences with THC-infused beverages in social and everyday settings. The study promises to shed light on the potential benefits, challenges, and overall impact of cannabis drinks on mood, wellness, and lifestyle choices, potentially revolutionizing the way people think about social drinking.

In this article, we will explore the background of THC-infused beverages, the details of the study, its significance for consumers and the cannabis industry, and the broader implications for public health and social norms.

 The Rise of THC-Infused Beverages: A New Frontier in Cannabis Consumption

Cannabis Meets Beverage Innovation

Cannabis beverages have emerged as one of the fastest-growing segments in the cannabis market. Unlike smoking or vaping, which can be harsh or socially stigmatized, cannabis-infused drinks offer a discreet, familiar, and often more enjoyable way to consume THC (tetrahydrocannabinol, the primary psychoactive compound in cannabis). These beverages include sparkling seltzers, teas, coffees, shots, mixers, and even dry powders that can be mixed with water or other liquids.

The appeal of cannabis drinks lies in their ease of use, consistent dosing, and the ability to combine cannabis with flavors and formats that appeal to a broad range of consumers, including those who do not traditionally use cannabis. THC beverages are often marketed as wellness products that promote relaxation, stress relief, and social enjoyment without the negative effects commonly associated with alcohol, such as hangovers, impaired judgment, or aggressive behavior.

Cannabis Seltzers: The New Social Drink

Among cannabis beverages, THC-infused seltzers have gained particular popularity. These sparkling, lightly flavored drinks resemble alcoholic hard seltzers, making them an attractive alternative for people seeking a similar social experience without alcohol’s downsides. THC seltzers typically contain measured doses of THC, allowing consumers to control their intake more precisely than with edibles or smoking.

The rise of cannabis seltzers coincides with growing trends toward mindful drinking and wellness-focused lifestyles. Many consumers are reducing or eliminating alcohol consumption due to health concerns, personal preferences, or lifestyle changes. THC-infused beverages offer a compelling option for those looking to maintain a social, celebratory atmosphere while avoiding alcohol’s negative effects.

The Study: Recruiting 2,000 Participants to Explore THC Beverages as Alcohol Alternatives

Recognizing the potential of cannabis beverages to transform social drinking, a coalition of THC-infused beverage companies—including Cycling Frog, Happi, Keef, Leisuretown, Mary Jones, and Pabst Labs—has partnered with MoreBetter, a data research firm, to conduct a landmark study. The study seeks to recruit 2,000 adults across legal cannabis states in the U.S. to participate in a three-week research program designed to capture real-world data on the effects of THC beverages compared to alcohol.

The primary goals of the study are to:

• Understand how consumers experience THC-infused beverages in everyday and social contexts.

• Measure changes in mood, anxiety, relaxation, sleep quality, and overall wellness when substituting cannabis drinks for alcohol.

• Evaluate consumer preferences, satisfaction, and potential side effects.

• Collect data that can inform product development, marketing, and public health policies around cannabis beverages.

Study Design and Methodology

The study is structured in three phases over three weeks:

• Baseline Week (Week 1): Participants track their mood, alcohol consumption, sleep quality, and overall wellness without using any THC beverages. This baseline data establishes a control for comparison.

• Intervention Weeks (Weeks 2 and 3): Participants receive free THC-infused beverages from a range of brands and product types, including seltzers, shots, dry powders, and mixers. They are encouraged to consume these products as an alternative to alcohol and continue logging their experiences daily.

• Data Collection and Analysis: All participant data is collected via the Releaf App, a cannabis-focused wellness platform that allows users to record subjective experiences such as relaxation, anxiety levels, mood, social enjoyment, and any side effects. The app also tracks frequency and quantity of beverage consumption.

This design allows researchers to compare participants’ experiences before and after substituting alcohol with THC beverages, providing valuable insights into the potential benefits and challenges of cannabis drinks as alcohol alternatives.

Early Findings and Consumer Feedback

Although the study is ongoing, preliminary data and early phases have yielded promising results that underscore the potential of THC beverages to disrupt traditional alcohol consumption patterns.

 Positive Consumer Experiences

• Preference for THC Drinks: Early survey results indicate that 72% of participants expressed a preference for THC-infused beverages over alcohol for future social occasions.

• High Satisfaction Rates: Approximately 96% of participants reported positive experiences with the cannabis drinks, highlighting feelings of relaxation, improved mood, and enhanced social enjoyment.

• Reduced Negative Side Effects: Many participants noted fewer adverse effects compared to alcohol, such as the absence of hangovers, reduced irritability, and less impaired coordination or judgment.

Wellness Benefits

Participants frequently reported that THC beverages helped reduce anxiety and stress, improved sleep quality, and contributed to a sense of calm without the grogginess or lethargy often associated with alcohol consumption. These wellness benefits align with the broader trend of consumers seeking products that support mental health and balanced lifestyles.

Challenges and Considerations

While the feedback has been largely positive, some participants mentioned challenges such as:

• Onset Time: THC beverages can take longer to produce effects compared to alcohol, which may require users to adjust expectations and consumption habits.

• Dosing Sensitivity: Some consumers found it challenging to find the right dose, especially those new to cannabis.

• Legal and Social Barriers: The study is limited to states where THC beverages are legal, and some participants expressed concerns about stigma or workplace policies.

Industry Implications: Shaping the Future of Cannabis Beverages

The data collected from this large-scale study will provide cannabis beverage companies with critical insights into consumer preferences, dosing habits, and desired effects. This information can guide the development of new products tailored to specific wellness goals, flavor profiles, and social occasions.

For example, brands may create lower-dose options for beginners, functional beverages targeting relaxation or sleep, or mixers designed for cannabis cocktails. Understanding how consumers use these products in real life will help companies innovate responsibly and meet market demand.

Marketing and Consumer Education

One of the biggest hurdles for cannabis beverages is consumer education. Unlike alcohol, where effects and social norms are well established, THC drinks require clear communication about dosing, onset times, and expected effects. The study’s findings can help brands craft accurate messaging that empowers consumers to make informed choices.

Additionally, demonstrating positive consumer outcomes may reduce stigma and encourage more adults to consider cannabis beverages as a viable alternative to alcohol.

Regulatory and Public Health Impact

As cannabis legalization expands, regulators are grappling with how to classify and oversee THC-infused beverages. Data from this study could inform policy decisions related to labeling, advertising, dosage limits, and public safety.

Public health officials may also benefit from understanding how cannabis drinks affect consumption patterns, particularly whether they reduce harmful alcohol use or introduce new risks. The study’s real-world evidence could contribute to balanced, science-based regulations that protect consumers while supporting industry growth.

Social and Cultural Significance: Redefining Social Drinking

The rise of THC-infused beverages coincides with a broader cultural shift toward mindful drinking—where consumers seek to reduce or eliminate alcohol for health, wellness, or personal reasons. Cannabis drinks offer an alternative that aligns with this trend by providing relaxation and social enjoyment without alcohol’s negative health impacts.

This shift could lead to new social norms where cannabis beverages become a mainstream option at parties, dinners, and celebrations, much like wine or beer today.

Large-scale studies and positive consumer experiences help normalize cannabis use by framing it as a wellness and lifestyle choice rather than a taboo or illicit activity. As more people try THC beverages and share their experiences, social acceptance is likely to grow.

This destigmatization can encourage more open conversations about cannabis, reduce misinformation, and foster a more inclusive cannabis culture.

How to Participate in the Study

For adults interested in participating, the study is open to those who:

• Are 21 years or older.

• Reside in states where THC-infused beverages are legally available.

• Are willing to track their alcohol and cannabis beverage consumption and wellness experiences via the Releaf App.

• Are open to substituting cannabis drinks for alcohol during the study period.

Participants receive free THC beverages from a variety of brands and product types, making it a unique opportunity to explore cannabis drinks firsthand while contributing to important research.

Conclusion

The recruitment of 2,000 participants for this pioneering study marks a significant milestone in the evolution of cannabis beverages. By systematically exploring how THC-infused drinks perform as alternatives to alcohol, this research promises to unlock valuable insights that could reshape consumer behavior, product innovation, regulatory frameworks, and social norms around cannabis use.

As cannabis seltzers and other THC beverages continue to gain popularity, understanding their real-world impact is essential for consumers, industry leaders, and policymakers alike. This study not only highlights the potential of cannabis drinks to offer a healthier, more enjoyable social experience but also signals a broader cultural shift toward mindful, wellness-oriented consumption.

For those curious about cannabis beverages or seeking alternatives to alcohol, this study offers a unique chance to participate in cutting-edge research and experience the future of social drinking firsthand.

DRINKERS WANT TO SWITCH TO CANNABIS, READ ON…

56% OF BEER DRINKS SAY THEY WOULD SWITCH TO CANNABIS BEVERAGES